NCT02549638 is a clinical trial of DNA Extraction in Carcinoma, Squamous Cell, sponsored by Mayo Clinic.

Who is sponsoring NCT02549638?

NCT02549638 is sponsored by Mayo Clinic.

What drugs are being tested in NCT02549638?

Interventions in NCT02549638: DNA Extraction.

What condition does NCT02549638 study?

NCT02549638 studies Carcinoma, Squamous Cell, Carcinoma, Squamous, Squamous Cell Carcinoma, Lung Neoplasms, Cancer of Lung, Cancer of the Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary, Pulmonary Cancer, Pulmonary Neoplasms.

Is NCT02549638 still recruiting?

NCT02549638 is currently terminated. Last updated 14 October 2025.

Last reviewed 2025-10-14 · How we verify

NCT02549638

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

Terminated Last updated 14 October 2025

What this trial tests

trial testing DNA Extraction in Carcinoma, Squamous Cell in 22 participants. Terminated before completion.

Timeline

8 April 2015

Primary endpoint
23 April 2020

23 April 2020

Quick facts

Lead sponsor	Mayo Clinic
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	22
Start date	8 April 2015
Primary completion	23 April 2020
Estimated completion	23 April 2020
Sites	1 location across United States

Drugs / interventions tested

DNA Extraction

Conditions studied

Carcinoma, Squamous Cell — all drugs for Carcinoma, Squamous Cell →
Carcinoma, Squamous — all drugs for Carcinoma, Squamous →
Squamous Cell Carcinoma — all drugs for Squamous Cell Carcinoma →
Lung Neoplasms — all drugs for Lung Neoplasms →

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Carcinoma, Squamous Cell or Carcinoma, Squamous. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will utilize both retrospective and prospective data collection from patients that already had a bronchoscopy and lung resection or will have a bronchoscopy and lung resection for squamous cell carcinoma. The investigators plan to prospectively collect 5 bronchoscopic biopsies, 10ml blood and one tumor and adjacent normal samples from 200 qualified patients who meet the study criteria.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Carcinoma, Squamous Cell

Currently open trials in the same condition.

NCT06912087 — Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC · Phase 1 · recruiting
NCT06669572 — Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment · Phase 2 · recruiting
NCT06383728 — Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma · Phase 2 · recruiting
NCT04481256 — TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapY · NA · recruiting
NCT04429542 — Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced · Phase 1 · recruiting

Other Mayo Clinic trials

Trials by the same sponsor.

NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02549638 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
Last refreshed: 14 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02549638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing